COMMUNIQUÉ DE PRESSE publié le 10/01/2025 à 00:00, il y a 1 année 4 mois MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test MedMira Inc. receives Health Canada authorization for clinical trials of Multiplo® Complete Syphilis Antibody Test. Innovative solution for active and past syphilis cases Clinical Trials MedMira Inc. Health Canada Syphilis Diagnostic Tool
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 23:05, il y a 1 année 4 mois Caldwell Reports First Quarter Results Talent acquisition firm Caldwell Partners Int'l Inc. (TSX:CWL)(OTCQX:CWLPF) reports Q1 fiscal 2025 financial results showing growth in professional fees and stable operations Financial Results Talent Acquisition Growth Caldwell Partners Professional Fees
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 22:45, il y a 1 année 4 mois Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness Onco-Innovations Limited announces exclusive PNKP inhibitors Technology for cancer treatment, potentially improving patient outcomes Technology Patient Outcomes Cancer Treatment PNKP Inhibitors Onco-Innovations Limited
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 22:00, il y a 1 année 4 mois Vision Marine Technologies Innovates HV Marine Battery Packs in Collaboration With Calip Group Vision Marine Technologies partners with Calip Group to establish a production line for custom cooling plates tailored for high-voltage marine battery packs. The collaboration aims to enhance thermal management and extend battery lifespan Vision Marine Technologies Thermal Management Calip Group Custom Cooling Plates High-voltage Marine Battery Packs
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 21:00, il y a 1 année 4 mois CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis CAGE Bio initiates Phase 2b trial for CGB-500, a topical JAK inhibitor ointment for atopic dermatitis. High efficacy, low side-effects. Improving patient outcomes Phase 2B Trial Atopic Dermatitis CAGE Bio CGB-500 Topical Therapy
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 20:30, il y a 1 année 4 mois Energy Northwest and EVCS to Boost Electric Vehicle Charging Along Highway 101 Energy Northwest and EVCS collaborate to install 40 DC Fast chargers along Highway 101 in rural Washington and Oregon, supported by a $14.6M grant. Project aims to enhance EV infrastructure on the US West Coast Grant DC Fast Chargers EV Infrastructure EVCS Energy Northwest
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 20:28, il y a 1 année 4 mois EQS-Adhoc: DATAGROUP will not pursue the spin-off of its subsidiary Almato AG DATAGROUP SE decides not to pursue the spin-off of Almato AG, citing uncertainties in achieving planned advantages. The company will focus on the development of Almato internally Shareholder Value DATAGROUP SE Strategic Decision Spin-off Almato AG
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 20:20, il y a 1 année 4 mois EQS-Adhoc: Shelly Group announces preliminary consolidated sales revenues FY 2024 Shelly Group SE announces 43% increase in consolidated sales revenues for FY 2024 to approximately EUR 107 million, slightly exceeding forecast. EBIT forecast for 2024 confirmed, revenue target for 2026 unchanged Revenue Forecast EBIT FY 2024 Shelly Group SE Consolidated Sales Revenues
COMMUNIQUÉ DE PRESSE publié le 09/01/2025 à 20:02, il y a 1 année 4 mois Ur-Energy Will Participate in the "2025 Mining Conference: Mining & Supplying Critical Minerals & Precious Metals" Presented by Maxim Group LLC on Thursday, January 16 Ur-Energy CEO John Cash to participate in 2025 Mining Conference hosted by Maxim Group LLC. Focus on critical minerals and precious metals. Conference to be held virtually Critical Minerals Precious Metals Mining Conference Ur-Energy Maxim Group
COMMUNIQUÉ RÉGLEMENTÉ publié le 09/01/2025 à 19:03, il y a 1 année 4 mois ALTAREIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE Bilan semestriel du contrat de liquidité d'Altareit avec Rothschild Martin Maurel : transactions et volume échangé au 2nd semestre 2024 conformément aux pratiques de marché admises Rothschild Martin Maurel Transactions ALTAREIT Liquidité Volume
Publié le 22/05/2026 à 19:35, il y a 23 heures 36 minutes PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Publié le 22/05/2026 à 18:05, il y a 1 jour 1 heure Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Publié le 22/05/2026 à 18:05, il y a 1 jour 1 heure Disclosure of transactions in own shares from May 18 to May 22, 2026
Publié le 22/05/2026 à 12:52, il y a 1 jour 6 heures Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Publié le 22/05/2026 à 12:52, il y a 1 jour 6 heures Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Publié le 23/05/2026 à 03:15, il y a 15 heures 56 minutes UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Publié le 23/05/2026 à 03:00, il y a 16 heures 11 minutes Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Publié le 23/05/2026 à 02:25, il y a 16 heures 46 minutes Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Publié le 23/05/2026 à 02:25, il y a 16 heures 46 minutes Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Publié le 23/05/2026 à 01:00, il y a 18 heures 11 minutes LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Publié le 23/05/2026 à 16:30, il y a 2 heures 41 minutes HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Publié le 23/05/2026 à 15:57, il y a 3 heures 14 minutes EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Publié le 22/05/2026 à 22:05, il y a 21 heures 6 minutes Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Publié le 22/05/2026 à 22:05, il y a 21 heures 6 minutes Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Publié le 22/05/2026 à 19:51, il y a 23 heures 20 minutes Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices